Drugs Made In America Acquisition Corp.
Organization details
- Legal name
- Drugs Made In America Acquisition Corp.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Financials
- SIC code
- 6770 — Blank Checks
- Headquarters city
- New York
- Headquarters state / province
- New York
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- DMAA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0002028614
Board of directors
-
Catherine Do · DirectorSince 2025
-
Lynn Stockwell · Director · CEO and Exe. Chair of BoardSince 2025
-
Myron W. Shulgan · DirectorSince 2025
-
Sridhar G. Prasad · DirectorSince 2025
Chief executives
Board connections
4 of this board's directors also sit on 1 other board. 1 is in the same sector.
-
Drugs Made In America Acquisition II Corp. Same sectorvia Catherine Do, Lynn Stockwell, Myron W. Shulgan and Sridhar G. Prasad
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 18, 2025 | Drugs Made In America Acquisition LLC 10% owner | Open-market purchase | +30,000 | — | — |
| Feb 18, 2025 | Lynn Stockwell Director, Officer (CEO and Exe. Chair of Board), 10% owner | Open-market purchase | +30,000 | — | — |
| Jan 29, 2025 | Drugs Made In America Acquisition LLC 10% owner | Open-market purchase | +400,000 | — | — |
| Jan 29, 2025 | Lynn Stockwell Director, Officer (CEO and Executive COB), 10% owner | Open-market purchase | +400,000 | — | — |
| Jan 29, 2025 | Myron W. Shulgan Director | Other | +100,000 | — | — |
| Jan 29, 2025 | Sridhar G. Prasad Director | Other | +100,000 | — | — |
| Jan 29, 2025 | Catherine Do Director | Other | +100,000 | — | — |
| Jan 29, 2025 | Worman Glenn C. Officer (CFO) | Other | +100,000 | — | — |
| Jan 29, 2025 | Drugs Made In America Acquisition LLC 10% owner | Other | −400,000 | — | — |
| Jan 29, 2025 | Lynn Stockwell Director, Officer (CEO and Executive COB), 10% owner | Other | −400,000 | — | — |
| Jan 29, 2025 | Drugs Made In America Acquisition LLC 10% owner | Open-market sale | −5,698,363 | — | — |
| Jan 29, 2025 | Lynn Stockwell Director, Officer (CEO and Executive COB), 10% owner | Open-market sale | −5,698,363 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Drugs Made In America Acquisition Corp.
Who is the CEO of Drugs Made In America Acquisition Corp.?
Lynn Stockwell has been Drugs Made In America Acquisition Corp.'s CEO and Exe. Chair of Board since January 2025.
How many directors are on Drugs Made In America Acquisition Corp.'s board?
Drugs Made In America Acquisition Corp.'s board has 4 directors: Catherine Do, Lynn Stockwell, Myron W. Shulgan and Sridhar G. Prasad.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="drugs-made-in-america-acquisition-corp"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.